Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.150
-0.080 (-3.59%)
At close: Sep 8, 2026, 4:00 PM EDT
2.190
-0.040 (-1.79%)
After-hours: Sep 8, 2026, 7:59 PM EDT
Intelligent Bio Solutions Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 3.99 | 1.02 | 6.3 | 1.54 | 8.24 |
Short-Term Investments | 0.15 | 0.13 | 0.11 | 0.12 | 0.05 |
Cash & Short-Term Investments | 4.14 | 1.15 | 6.42 | 1.66 | 8.28 |
Cash Growth | 261.51% | -82.14% | 287.53% | -80.02% | -34.11% |
Accounts Receivable | 0.85 | 0.59 | 0.43 | 0.29 | 1.53 |
Other Receivables | 0.83 | 1.07 | 0.55 | 0.54 | 0.44 |
Receivables | 1.67 | 1.67 | 0.98 | 0.83 | 2.47 |
Inventory | 0.42 | 0.64 | 0.78 | 0.98 | - |
Prepaid Expenses | 0.86 | 0.36 | 0.36 | 0.36 | 0.12 |
Other Current Assets | - | 0.33 | - | 0.03 | - |
Total Current Assets | 7.1 | 4.14 | 8.53 | 3.86 | 10.87 |
Property, Plant & Equipment | 2.05 | 0.32 | 0.87 | 1.24 | 0.39 |
Other Intangible Assets | 2.8 | 3.79 | 4.37 | 5.26 | - |
Long-Term Accounts Receivable | - | - | - | - | 1.09 |
Total Assets | 11.94 | 8.25 | 13.78 | 10.35 | 12.35 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 0.71 | 0.9 | 0.6 | 1.2 | 0.72 |
Accrued Expenses | 2.82 | 2 | 1.57 | 1.56 | 1.11 |
Current Portion of Long-Term Debt | - | 0.2 | 0.52 | 0.35 | - |
Current Portion of Leases | 0.15 | 0.08 | 0.27 | 0.22 | - |
Current Unearned Revenue | - | - | 2.49 | 2.34 | 2.84 |
Other Current Liabilities | 1.25 | 2.17 | - | 0.21 | - |
Total Current Liabilities | 4.93 | 5.35 | 5.45 | 5.88 | 4.66 |
Long-Term Debt | - | - | - | 0.4 | - |
Long-Term Leases | 1.67 | - | 0.08 | 0.36 | - |
Long-Term Unearned Revenue | - | - | - | - | 1.09 |
Pension & Post-Retirement Benefits | 0.05 | 0.08 | 0.06 | 0.02 | 0.05 |
Total Liabilities | 6.65 | 5.44 | 5.6 | 6.67 | 5.81 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 0.03 | 0.01 | 0.03 | 0 | 0.01 |
Additional Paid-In Capital | 80.99 | 65.85 | 60.97 | 46.18 | 38.58 |
Retained Earnings | -74.96 | -62.53 | -51.96 | -41.81 | -31.18 |
Treasury Stock | -0 | -0 | -0 | -0 | - |
Comprehensive Income & Other | -0.55 | -0.33 | -0.71 | -0.58 | -0.79 |
Total Common Equity | 5.51 | 3 | 8.33 | 3.8 | 6.62 |
Minority Interest | -0.22 | -0.18 | -0.15 | -0.11 | -0.08 |
Shareholders' Equity | 5.29 | 2.81 | 8.18 | 3.69 | 6.55 |
Total Liabilities & Equity | 11.94 | 8.25 | 13.78 | 10.35 | 12.35 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 1.82 | 0.28 | 0.87 | 1.34 | - |
Net Cash (Debt) | 2.32 | 0.86 | 5.54 | 0.32 | 8.28 |
Net Cash Growth | 168.85% | -84.42% | 1633.80% | -96.14% | -34.11% |
Net Cash Per Share | 1.58 | 1.64 | 34.81 | - | - |
Filing Date Shares Outstanding | 3.03 | 0.9 | 0.42 | 0.02 | - |
Total Common Shares Outstanding | 2.91 | 0.73 | 0.35 | 0.02 | - |
Working Capital | 2.17 | -1.21 | 3.08 | -2.02 | 6.2 |
Book Value Per Share | 1.90 | 4.09 | 24.10 | 195.74 | - |
Tangible Book Value | 2.71 | -0.79 | 3.96 | -1.46 | 6.62 |
Tangible Book Value Per Share | 0.93 | -1.08 | 11.45 | -75.04 | - |
Machinery | 0.12 | 0.08 | 0.06 | 0.06 | - |
Construction In Progress | - | - | 0.54 | 0.65 | 0.39 |
Leasehold Improvements | 0.02 | 0.02 | 0.02 | 0.02 | - |